Skip to main content
CANN GROUP LIMITED logo

CANN GROUP LIMITED — Investor Relations & Filings

Ticker · CAN ISIN · AU000000CAN2 LEI · 529900XX42XELLXVQE42 ASX Manufacturing
Open in API
Filings indexed 729 across all filing types
Latest filing 2020-12-14 Capital/Financing Update
Country AU Australia
Listing ASX CAN

About CANN GROUP LIMITED

https://www.canngrouplimited.com/

Cann Group Limited specializes in the cultivation, manufacture, and supply of medicinal cannabis products. The company focuses on providing pharmaceutical-grade cannabis for therapeutic use, utilizing advanced greenhouse technology and automated cultivation systems to ensure standardized quality and consistency. Its operations encompass the entire supply chain, from plant genetics and breeding to the production of finished medicinal products, including oils and dried flower. Cann Group serves healthcare professionals and patients through established distribution channels and maintains a focus on research and development to advance cannabinoid-based treatments. The company leverages large-scale production capabilities to meet growing demand in both domestic and international medicinal markets, emphasizing rigorous quality control and compliance with international pharmaceutical standards.

Recent filings

Filing Released Lang Actions
Execution of bank facility documentation 1 page 179
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 15 December 2020 regarding the execution of final documentation on a $50 million bank debt facility with National Australia Bank. It details the terms of the loan, including interest rates and fees, and the intended use of the funds for a medicinal cannabis production site. The document is short (2199 characters) and focuses on financing activity rather than financial results or reports. There is no indication that this is a full financial report, audit, or earnings release. The content clearly relates to an update on the company's capital structure and financing arrangements. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2020-12-14 English
Change of Director's Interest Notice 2 pages 284.5KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rules and the Corporations Act. It details changes in a director's relevant interests in securities, including the number of shares held before and after the change, nature of the change, and related parties. This type of document is a formal notification of insider share transactions by a company director. It does not contain financial performance data, management discussion, or other report content. Therefore, it fits the category of Director's Dealing (DIRS). The document length and content confirm it is not a brief announcement or a report publication notice but a full notice of director's interest change.
2020-12-10 English
Appendix 2A 15 pages 306.7KB
Regulatory Filings Classification · 95% confidence The document is an Appendix 2A form, which is an application for quotation of securities on the ASX (Australian Securities Exchange). It includes detailed information about the entity, the type of securities being quoted, and references to previous announcements such as Appendix 3B. The document is a formal regulatory filing related to securities issuance and quotation, not a financial report, earnings release, or management discussion. It is not a report publication announcement since it contains substantive information and is not merely announcing the availability of a report. The document fits the category of Regulatory Filings (RNS) as it is a compliance document submitted to the exchange for regulatory purposes and does not fall under other more specific categories like Capital/Financing Update or Share Issue/Capital Change, which are typically announcements rather than the formal application form itself.
2020-11-26 English
Cleansing statement - issue of shares to CSIRO 1 pa
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 27 November 2020, providing notice under section 708A(5)(e) of the Corporations Act 2001. It details the issuance of 75,000 fully paid ordinary shares by way of placement to a sophisticated investor (CSIRO) as part settlement of invoices, without disclosure under Part 6D.2 of the Corporations Act. The notice confirms compliance with relevant sections of the Corporations Act and states no excluded information is required to be disclosed. The document is short (2565 characters) and is a formal regulatory notice about a share placement event, not a full financial report or detailed capital update. It fits the category of a Regulatory Filing (RNS) as it is a compliance announcement under the Corporations Act and does not contain substantive financial data or detailed capital structure changes that would classify it as a Capital/Financing Update (CAP).
2020-11-26 English
Proposed issue of Securities - CAN 5 pages 27.6KB
Capital/Financing Update Classification · 100% confidence The document is an announcement regarding a proposed issue of securities by Cann Group Limited. It details the number of securities to be issued, the issue price, approval dates, and other conditions related to the placement or issue of shares. There is no financial statement or comprehensive financial report included, but rather a formal notification of a capital raising event. This fits the definition of a Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes. The document length is about 5,157 characters, which is sufficient for a detailed announcement but does not constitute a full financial report. Therefore, the correct classification is CAP.
2020-11-25 English
Debt facility update 1 page 180.0KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 25 November 2020 providing details about the terms of a $50 million bank debt facility with National Australia Bank. It discusses interest rates, fees, and the purpose of the loan for a medicinal cannabis production site. There are no financial statements, comprehensive financial data, or detailed analysis typical of financial reports. The document is an update on financing terms, which fits the category of Capital/Financing Update (CAP). The document length is short (2595 characters), and it is not a report publication announcement or certification. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2020-11-24 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.